Rheumatoid Arthritis 2025 Epidemiology Study by Risk Factors, Global Trends and Limitations

Rheumatoid Arthritis 2025 Epidemiology Study by Risk Factors,
Global Trends and Limitations
“The Rheumatoid Arthritis (RA) EpiCast Report provides an overview of the
risk factors and global trends of RA in the eight major markets (8MM) (US,
France, Germany, Italy, Spain, UK, Japan, and Australia).
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and
cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body.
In RA, the body's immune system attacks the lining of the joints, known as the synovial membrane, or synovium,
causing an inflammatory response. The disease can lead to premature mortality, disability, and decreased
quality of life.
In the 8MM, epidemiologists forecast that the diagnosed incident cases of RA will increase from 195,592 cases
in 2015 to 216,467 cases in 2025, at an Annual Growth Rate (AGR) of 1.07%. The US will have the highest number
of diagnosed incident cases of RA among the 8MM throughout the forecast period, while Spain will have the
lowest.
In the 8MM, epidemiologists forecast that the diagnosed prevalent cases of RA will increase from 4,354,194
cases in 2015 to 4,931,572 cases in 2025, at an AGR of 1.33%. The US will have the highest number of diagnosed
prevalent cases of RA among the 8MM throughout the forecast period, while Australia will have the lowest.
Browse Detail Market Report With TOC @ http://www.hexareports.com/report/epicast-reportrheumatoid-arthritis-epidemiology-forecast-to-2025
Follow Us:
In the 8MM, epidemiologists forecast that the total prevalent cases of RA will increase from 6,137,523 cases in
2015 to 6,971,304 cases in 2025, at an AGR of 1.36%. The US will have the highest number of total prevalent
cases of RA among the 8MM throughout the forecast period, while Australia will have the lowest.
Epidemiologists utilized data from county-specific studies published in peer-reviewed journals as well as data
obtained from primary research. In order to ensure comparability of the incidence and prevalence across
markets, epidemiologists used sources that provided the diagnosed incidence and total prevalence of RA based
on the 1987 American College of Rheumatology (ACR) criteria for the classification of RA.
Scope of this Report:
 The Rheumatoid Arthritis (RA) EpiCast Report provides an overview of the risk factors and global trends of
RA in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It
includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases,
and total prevalent cases of RA segmented by age and sex in these eight markets. The diagnosed prevalent
cases of RA are further segmented by severity in the 8 MM for the forecast period.
 The RA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
 The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of
disease trends in the 8MM.
Request A Sample copy of This Report @ http://www.hexareports.com/report/epicast-reportrheumatoid-arthritis-epidemiology-forecast-to-2025/request-sample
Reasons To Buy
The RA EpiCast report will allow you to 1. Develop business strategies by understanding the trends shaping and driving the global RA market.
2. Quantify patient populations in the global RA market to improve product design, pricing, and launch
plans.
3. Organize sales and marketing efforts by identifying the age groups and sex that present the best
opportunities for RA therapeutics in each of the markets covered.
4. Identify the percentage of diagnosed prevalent cases of RA by severity.
Explore Related Reports:
 United States Computed Tomography (CT) Systems Market to 2022
http://www.hexareports.com/report/united-states-contrast-media-injectors-market-outlook-to-2022
 United States Contrast Media Injectors Market Outlook to 2022
http://www.hexareports.com/report/united-states-contrast-media-injectors-market-outlook-to-2022
 United States Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022
http://www.hexareports.com/report/united-states-magnetic-resonance-imaging-mri-systems-marketoutlook-to-2022
Follow Us:
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Follow Us:

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body.

Download Report